Tea Lanišnik Rižner (Tea L Rižner)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 18

Top Topics

Endometrial Cancer

Estrogen Receptor

Machine Learning

Inferior Vena Cava

Top Venues

International journal of molecular sciences

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Tea Lanišnik Rižner, Marija Gjorgoska
Steroid sulfatase and sulfotransferases in the estrogen and androgen action of gynecological cancers: current status and perspectives. Essays in biochemistry (2024)
Marko Hojnik, Maša Sinreih, Maja Anko, Neli Hevir-Kene, Tamara Knific, Boštjan Pirš, Snježana Frković Grazio, Tea Lanišnik Rižner
The Co-Expression of Estrogen Receptors ERα, ERβ, and GPER in Endometrial Cancer. International journal of molecular sciences 24 (3) (2023)
Marko Hojnik, Maša Sinreih, Maja Anko, Neli Hevir-Kene, Tamara Knific, Boštjan Pirš, Snježana Frković Grazio, Tea Lanišnik Rižner
The Co-Expression of Estrogen Receptors ERα, ERβ, and GPER in Endometrial Cancer. International journal of molecular sciences 24 (3) (2023)
Luka Roškar, Marko Kokol, Renata Pavlič, Irena Roškar, Špela Smrkolj, Tea Lanišnik Rižner
Decreased Gene Expression of Antiangiogenic Factors in Endometrial Cancer: qPCR Analysis and Machine Learning Modelling. Cancers 15 (14) (2023)
Vid Janša, Maja Pušić, Helena Ban Frangež, Tea Lanišnik Rižner
TGFBI as a candidate biomarker for non-invasive diagnosis of early-stage endometriosis. Human reproduction (Oxford, England) (2023)
Marko Hojnik, Maša Sinreih, Maja Anko, Neli Hevir-Kene, Tamara Knific, Boštjan Pirš, Snježana Frković Grazio, Tea Lanišnik Rižner
The Co-Expression of Estrogen Receptors ERα, ERβ, and GPER in Endometrial Cancer. International journal of molecular sciences 24 (3) (2023)
Marko Hojnik, Maša Sinreih, Maja Anko, Neli Hevir-Kene, Tamara Knific, Boštjan Pirš, Snježana Frković Grazio, Tea Lanišnik Rižner
The Co-Expression of Estrogen Receptors ERα, ERβ, and GPER in Endometrial Cancer. International journal of molecular sciences 24 (3) (2023)
Renata Pavlič, Marija Gjorgoska, Tea Lanišnik Rižner
Model Cell Lines and Tissues of Different HGSOC Subtypes Differ in Local Estrogen Biosynthesis. Cancers 14 (11) (2022)
Maja Pušić, Teja Klančič, Tamara Knific, Andrej Vogler, Ronny Schmidt, Christoph Schröder, Tea Lanišnik Rižner
Antibody Arrays Identified Cycle-Dependent Plasma Biomarker Candidates of Peritoneal Endometriosis. Journal of personalized medicine 12 (6) (2022)
Maša Sinreih, Klara Gregorič, Kristina Gajser, Tea Lanišnik Rižner
Physiological Concentrations of Cimicifuga racemosa Extract Do Not Affect Expression of Genes Involved in Estrogen Biosynthesis and Action in Endometrial and Ovarian Cell Lines. Biomolecules 12 (4) (2022)
Marko Hojnik, Nataša Kenda Šuster, Špela Smrkolj, Damjan Sisinger, Snježana Frković Grazio, Ivan Verdenik, Tea Lanišnik Rižner
AKR1B1 as a Prognostic Biomarker of High-Grade Serous Ovarian Cancer. Cancers 14 (3) (2022)
Marko Hojnik, Snježana Frković Grazio, Ivan Verdenik, Tea Lanišnik Rižner
AKR1B1 and AKR1B10 as Prognostic Biomarkers of Endometrioid Endometrial Carcinomas. Cancers 13 (14) (2021)
Marija Gjorgoska, Tea Lanišnik Rižner
Estrogens and the Schrödinger's Cat in the Ovarian Tumor Microenvironment. Cancers 13 (19) (2021)
Luka Roškar, Irena Roškar, Tea Lanišnik Rižner, Špela Smrkolj
Diagnostic and Therapeutic Values of Angiogenic Factors in Endometrial Cancer. Biomolecules 12 (1) (2021)
Renata Pavlič, Suzana Vidic, Maja Anko, Tamara Knific, Tomaž Büdefeld, Kristina Marton, Maša Sinreih, Stefan Poschner, Walter Jäger, Snježana Frković-Grazio, Tea Lanišnik Rižner
Altered Profile of E1-S Transporters in Endometrial Cancer: Lower Protein Levels of ABCG2 and OSTβ and Up-Regulation of SLCO1B3 Expression. International journal of molecular sciences 22 (8) (2021)
Luka Roškar, Teja Klančič, Tamara Knific, Tea Lanišnik Rižner, Špela Smrkolj
Tie-2, G-CSF, and Leptin as Promising Diagnostic Biomarkers for Endometrial Cancer: A Pilot Study. Journal of clinical medicine 10 (4) (2021)
Marco Mottinelli, Maša Sinreih, Tea Lanišnik Rižner, Mathew P Leese, Barry V L Potter
N-Phenyl-1,2,3,4-tetrahydroisoquinoline: An Alternative Scaffold for the Design of 17β-Hydroxysteroid Dehydrogenase 1 Inhibitors. ChemMedChem 16 (1) (2020)
Marko Hojnik, Nataša Kenda Šuster, Špela Smrkolj, Snježana Frković Grazio, Ivan Verdenik, Tea Lanišnik Rižner
AKR1C3 Is Associated with Better Survival of Patients with Endometrial Carcinomas. Journal of clinical medicine 9 (12) (2020)